Business Context and Reporting Period
This Form 6-K filing by GSK plc, dated November 24, 2025, reports a transaction in the company's own shares. The filing covers share repurchase activities executed on November 21, 2025, as part of an existing buyback programme.
Key Financial Metrics
The filing details a specific share repurchase transaction rather than comprehensive financial statements. Key metrics for the reported transaction include:
- Shares Purchased: 180,000 ordinary shares.
- Price Range: Lowest price paid was 1,753.00 GBp; highest price paid was 1,783.00 GBp.
- Average Price: Volume-weighted average price paid was 1,766.33 GBp.
- Treasury Holdings: Following this purchase, GSK holds 235,602,844 ordinary shares in treasury.
- Shares in Issue: 4,079,829,083 ordinary shares (excluding treasury shares).
- Voting Rights: Treasury shares represent 5.77% of total voting rights.
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
Since the announcement of the non-discretionary agreement with BNP Paribas SA on September 30, 2025, GSK has purchased a total of 10,138,000 ordinary shares. The November 21 transaction increased the total treasury share count to 235,602,844.
Guidance, Outlook, and Risks
The filing contains no new financial guidance or management commentary regarding operational outlook. It includes a standard cautionary statement noting that forward-looking statements are subject to risks and uncertainties, referencing the "Risk Factors" section in GSK's 2024 Annual Report on Form 20-F and Q3 2025 results.
Investor Verification Checklist
- Verify the total remaining authorization under the buyback programme announced on September 30, 2025.
- Confirm the impact of the 5.77% treasury share holding on earnings per share (EPS) calculations.
- Review the "Risk Factors" in the 2024 Form 20-F for context on the cautionary statement regarding forward-looking projections.
- Check subsequent filings for updates on the total volume of shares repurchased under the current programme.